Tag archive for ‘Neurastem’
Neuralstem: Investigators are Very Positive on NSI-566 Results in ALS (CUR, Buy, $3.27)
Investment Perspective The key investigators for the treatment of ALS with Neuralstem’s NSI-566 neural stem cells have been extremely positive in public statements. They are Dr. Eva Feldman, the lead investigator for the trial, and Dr. Jonathan Glass. Dr. Feldman is Professor of Medicine at the University of Michigan Health Care System and past President […]